Commentary

Podcast

Pharmacy Focus: Oncology Edition - PARP Inhibitors in Ovarian Cancer

Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

In the second episode of Pharmacy Focus: Oncology Edition, Kirollos Hanna, PharmD, BCPS, BCOP, discussed how PARP inhibitors have changed the treatment landscape of ovarian cancer.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Hematology -- Image credit: DIgilife | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Related Content
3D rendering of a CAR T cell | Image Credit: © furyon - stock.adobe.com
July 15th 2025

Large Real-World Study Validates Idecabtagene Vicleucel Outcomes Seen in KarMMa Trial

Alexandra Gerlach, Associate Editor
COBRRA Trial Results Raise Questions About VTE Management
July 15th 2025

COBRRA Trial Results Raise Questions About VTE Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
3D rendering of antibody drug conjugate | Image Credit: Alpha Tauri 3D - stock.adobe.com
July 14th 2025

Adjuvant Trastuzumab Emtansine Plus Trastuzumab Improved Disease-Free, Overall Survival in HER2+ Early Breast Cancer

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
July 10th 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
New England Journal of Medicine website | Image Credit: © Oleksandr - stock.adobe.com
July 14th 2025

Publication Bias—as Old as Science Itself?

Curtis E. Haas, PharmD, FCCP
Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland - Image credit: Dr_Microbe | stock.adobe.com
July 14th 2025

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Kennedy Ferruggia, Assistant Editor